An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.
Braunwald
E
E
Department of Medicine, Harvard Medical School, Boston, MA.
Cannon
C P
CP
McCabe
C H
CH
D002561:Cerebrovascular Disorders / Q000453:epidemiology; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D012770:Shock, Cardiogenic / Q000453:epidemiology; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
D005343:Fibrinolytic Agents